Press Release – June 21, 2012
Avery Biomedical Devices, manufacturer of the Avery Diaphragm Pacing System System, has named Dilys M. Gore, Ph.D. as its Chief Science Officer.
Dr. Gore is a Ph.D. qualified bioengineer with over 30 years of experience with Avery Diaphragm Pacing Systems and other medical devices. As Chief Science Officer, Dr. Gore, in addition to her current responsibilities as European Manager, will lead the company research and development efforts.
Dr. Gore states, “I am thrilled to be able to further contribute to the growth of ABD.”
“We are honored to have Dr. Gore lead our efforts in future product development,” noted Linda Towler, CEO of Avery Biomedical Devices. “Her scientific experience and expertise will be invaluable in our continued efforts to best serve those who benefit from our products.”
About Diaphragm Pacing Systems
An Avery Diaphragm Pacing System is a surgically implanted phrenic nerve, or diaphragm, stimulator. It provides a far lower cost of care and a much higher quality of life for ventilator dependent patients with quadriplegia, central sleep apnea and diaphragm paralysis.
Avery Diaphragm Pacing Systems are the only diaphragm pacing system to have full premarket approval by the US FDA for adult and pediatric use. By using implanted radiofrequency receivers and external antennas, Avery Diaphragm Pacing Systems do not have percutaneous connectors which can result in chronic infections and ongoing wound management issues for caregivers.